IVC Evidensia

Overview

IVC Evidensia describes itself as “building the world’s best veterinary group.” The company was formed through the 2017 merger of Independent Vetcare (IVC) and Swedish company Evidensia.

UK Presence

In the UK, IVC Evidensia operates under several well-known brands and has acquired many previously independent practices. Their rapid expansion through acquisitions has made them one of the dominant players in the UK veterinary market.

Ownership Structure

The company is majority-owned by private equity firms:

• EQT Partners (Sweden) - 45% stake
• Silver Lake (USA) - 25% stake
• Nestlé S.A. (Switzerland) - 30% minority stake

Regulatory Matters

In 2024, the Competition and Markets Authority (CMA) launched a market investigation into the veterinary services sector, examining concerns about pricing, transparency, and competition. IVC Evidensia, as one of the largest corporate groups, was a focus of this investigation. The CMA’s final report (March 2026) found the market is not working well for pet owners and set out a package of remedies, including clearer ownership disclosure and pricing transparency.

In July 2026 the government accepted all of the CMA’s recommendations in its white paper Our vision for a thriving veterinary sector, committing to replace the Veterinary Surgeons Act 1966 with new legislation that will license veterinary businesses — including large corporate groups like IVC Evidensia — and introduce a binding consumer redress scheme, expected to be delivered through a new veterinary ombudsman.

What Pet Owners Should Know

• Practices owned by IVC Evidensia may not always clearly display their corporate ownership
• Prices and policies may be influenced by corporate strategy rather than local decision-making
• Staff turnover can sometimes affect continuity of care